2015
DOI: 10.1007/s10989-015-9487-3
|View full text |Cite
|
Sign up to set email alerts
|

Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation

Abstract: A small library of anticancer, cell-permeating, stapled peptides based on potent dual-specific antagonist of p53–MDM2/MDMX interactions, PMI-N8A, was synthesized, characterized and screened for anticancer activity against human colorectal cancer cell line, HCT-116. Employed synthetic modifications included: S-alkylation-based stapling, point mutations increasing hydrophobicity in key residues as well as improvement of cell-permeability by introduction of polycationic sequence(s) that were woven into the sequen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 148 publications
(198 reference statements)
0
12
0
Order By: Relevance
“…Specifically, while ( i , i +3 ) staples of various chemistries have been reported, these reports do not examine the compatibility of helical structure with stapling of two d -amino acids at ( i , i +3 ) positions. 48,7073 Another relevant feature of DD5-o is an extended hydrophobic surface of over 750 Å 2 which includes the staple and the required hot spot residues. This hydrophobic surface wraps around more than half of the helix (Figure 4c).…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, while ( i , i +3 ) staples of various chemistries have been reported, these reports do not examine the compatibility of helical structure with stapling of two d -amino acids at ( i , i +3 ) positions. 48,7073 Another relevant feature of DD5-o is an extended hydrophobic surface of over 750 Å 2 which includes the staple and the required hot spot residues. This hydrophobic surface wraps around more than half of the helix (Figure 4c).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Micewicz et al have used a range of distinctive S ‐alkylation staplings, with cysteines at ( i , i + 3), ( i , i + 4), ( i , i + 5) or ( i , i + 6) positions, in combination with amino acid mutations to design a library of over sixty stapled peptides in a search for antagonists of the p53‐mdm2/mdmx interaction. The peptide ligand that showed greatest cell permeability and in vivo antitumor activity in mice at low dose (3 mg) was an ( i , i + 3) o ‐xylene crosslinked peptide (AbB14Co) equipped with multiple Arg residues (Figure ) …”
Section: Chemical Approaches For Cysteine Staplingmentioning
confidence: 99%
“… An o ‐xylene stapled peptide with in vivo anticancer activity in a mouse model of cancer (AbB14Co) derived from a linear phage‐display peptide epitope (PMI‐N84) ( d ‐residues are underlined, Pf5 = pentafluorophenylalanine, Nal = 1‐naphthylalanine) …”
Section: Chemical Approaches For Cysteine Staplingmentioning
confidence: 99%
See 1 more Smart Citation
“…Cysteine‐mediated macrocycle formation has also been an effective conformational constraint, due to the sulfhydryl reactivity profile and the encodability of this natural amino acid . Various methods have been employed for macrocyclization, including S‐alkylation with bis‐electrophiles, S N Ar, and thiol‐ene reactions to form thioethers. Determining what factors affect cell penetration of crosslinked peptides has recently been assessed by Walensky et al., who determined that hydrophobicity, α‐helicity, and pI are the driving factors of cellular uptake .…”
Section: Introductionmentioning
confidence: 99%